BENCHMARK PROFILE
Midwest Compounds
Latest sync: Oct 3, 2026, 9:44 AM. Source coverage currently reflects PB Evidence data.
Readers who want a short single-vial catalog paired with batch certificates that can be opened on the laboratory’s own site.
Vendor-stated: operates out of Missouri, ships across the continental United States, and offers free shipping over $150. Contact lists [email protected] and weekday hours in Central Time. No street address was published. Observed September 24, 2026.
Unrelated to Midwest Peptide (midwestpeptide.com). Both print Freedom search codes that start with Midw; read the client line. BB is the vendor’s name for a BPC-157 and TB-500 vial, and the certificate names thymosin beta-4 with BPC-157. GLOW, NAD+, semaglutide 10 mg, and tirzepatide 10 mg were listed without a public certificate on the review date.
A Missouri-stated research storefront with public single-vial prices and a public certificate index whose reports link directly to Freedom Diagnostics under the Midwest Compounds client name.
Midwest Compounds lists a small catalog of single-vial research peptides with prices on the product pages, including the house name BB for a BPC-157 and TB-500 blend. The public COA index links each published batch to a Freedom Diagnostics report. PeptideBenchmark uses the regular list price and keeps free shipping over $150 as a vendor-stated checkout term.
The public COA index links each published batch to a report hosted at Freedom Diagnostics that resolves under the Midwest Compounds client name, supporting identity, HPLC/LC-MS purity, and net content. A strength-specific report is not treated as testing every other strength, and storefront purity marketing is not inherited onto sterility or endotoxin panels the reports do not run.
This vendor is one of 130 names currently included in our manual curated research-vendor layer.
This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.
- Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
- Look for repeated product-level behavior across the catalog, not just one showcase example.
- Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
Midwest Compounds is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.
Readers can leave the vendor marketing layer and inspect verification publicly.
This is the strongest public pattern because the verification step routes into an outside provider layer.
Current review touched 20 products and 22 document/link destinations.
1 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.
Score 7.4 from pb evidence score.
PB Curated Assessment: Strong. This is our own trust/transparency rubric and is kept separate from the PB score.
Under the formula retired on Aug 28, 2026 this vendor scores 7.53 — the live evidence-first score is 8.20 (+0.67). What changed and why: scoring methodology.
Assayed content is not fill accuracy. Laboratories report net peptide content, and peptides ship as salts, so an honestly filled vial commonly assays below its gross label — a figure under 100% is not evidence of a short vial. These numbers are also not comparable between vendors: they exist only where a laboratory reports net content, so they partly reflect which laboratory a vendor uses.
Holding a certificate for this vendor that is not here? Send it to the archive →
Same third-party review signals shown on the vendor board. Click Trustpilot or Pep Review Pro to open the source profile.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- No Finnrick score currently linked
- No Peptide Critic score currently linked
- No Trustpilot profile currently linked
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.